These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 33388217)

  • 21. [Gout and cardiovascular risk].
    Němec P
    Vnitr Lek; 2014 Oct; 60(10):893-901. PubMed ID: 25382012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidemiology of uric acid and fructose.
    Rho YH; Zhu Y; Choi HK
    Semin Nephrol; 2011 Sep; 31(5):410-9. PubMed ID: 22000647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uric acid: role in cardiovascular disease and effects of losartan.
    Alderman M; Aiyer KJ
    Curr Med Res Opin; 2004 Mar; 20(3):369-79. PubMed ID: 15025846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum uric acid and cardiovascular risk: state of the art and perspectives.
    Fenech G; Rajzbaum G; Mazighi M; Blacher J
    Joint Bone Spine; 2014 Oct; 81(5):392-7. PubMed ID: 24565888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should we be more aware of gender aspects in hyperuricemia? Analysis of the population-based German health interview and examination survey for adults (DEGS1).
    Engel B; Hoffmann F; Freitag MH; Jacobs H
    Maturitas; 2021 Nov; 153():33-40. PubMed ID: 34654526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
    Eliseev MS; Novikova AM
    Ter Arkh; 2019 May; 91(5):120-128. PubMed ID: 32598686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Asymptomatic hyperuricemia is not an independent risk factor for cardiovascular events or overall mortality in the general population of the Busselton Health Study.
    Nossent J; Raymond W; Divitini M; Knuiman M
    BMC Cardiovasc Disord; 2016 Dec; 16(1):256. PubMed ID: 27978810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of urate-lowering treatment on cardiovascular and renal disease: evidence from CARES, FAST, ALL-HEART, and FEATHER studies.
    Pontremoli R
    Curr Med Res Opin; 2017 Nov; 33(sup3):27-32. PubMed ID: 28952388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of hyperuricemia in vascular disorders.
    Edwards NL
    Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.
    Viazzi F; Leoncini G; Ratto E; Pontremoli R
    J Clin Hypertens (Greenwich); 2006 Jul; 8(7):510-8. PubMed ID: 16849905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country.
    Conen D; Wietlisbach V; Bovet P; Shamlaye C; Riesen W; Paccaud F; Burnier M
    BMC Public Health; 2004 Mar; 4():9. PubMed ID: 15043756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperuricemia, Type 2 Diabetes Mellitus, and Hypertension: an Emerging Association.
    Mortada I
    Curr Hypertens Rep; 2017 Sep; 19(9):69. PubMed ID: 28770533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
    Johnson RJ; Kang DH; Feig D; Kivlighn S; Kanellis J; Watanabe S; Tuttle KR; Rodriguez-Iturbe B; Herrera-Acosta J; Mazzali M
    Hypertension; 2003 Jun; 41(6):1183-90. PubMed ID: 12707287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HYPERURICEMIA AND POTENTIAL RISK OF CARDIOVASCULAR AND RENAL DISEASES].
    Schils R; Krzesinski JM
    Rev Med Liege; 2016 May; 71(5):262-8. PubMed ID: 27337847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.
    Mallat SG; Al Kattar S; Tanios BY; Jurjus A
    Curr Hypertens Rep; 2016 Oct; 18(10):74. PubMed ID: 27696189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice].
    Fomin VV; Morosova TE; Tsurko VV
    Ter Arkh; 2019 Dec; 91(12):75-83. PubMed ID: 32598593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperuricemia as a risk factor for cardiovascular disease: clinical review.
    Gudiño Gomezjurado Á
    Medwave; 2016 Nov; 16(10):e6606. PubMed ID: 27922586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hyperuricemia in hypertension: any clinical implication?].
    Deléaval P; Burnier M
    Rev Med Suisse; 2005 Sep; 1(32):2072-4, 2077-9. PubMed ID: 16238227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.